17 April 2020

ESMA Guidelines on performance fees in UCITS and certain types of AIFs

The European Securities and Markets Authority published its final report on the guidelines on performance fees in UCITS and certain types of AIFs on 3 April 2020 (the “Guidelines”).

The Guidelines apply to management companies of undertakings for collective Investments in transferable securities and to alternative investment fund managers that manage alternative investment funds, which are marketed to retail investors.

Print


Press contact
Beate Dünschede
+352 271802-29
beate.duenschede@gsk-lux.com

Back

GSK Updates
  • 07.05.2021

    GSK Update: Introducing the new sustainable finance measures of the EU Commission

    Read more
  • 30.03.2021

    GSK Update: SFDR – new RTS – What you should know

    Read more
  • 10.02.2021

    GSK Update: Blockchain II Law: Another step forward for the digitalization of EU capital markets

    Read more
Contact person

Dr. Marcus Peter, LL.M.

Partner

+352 271802-50

marcus.peter@gsk-lux.com

Dr. Marcel Bartnik

Local Partner

+352 271802-80

marcel.bartnik@gsk-lux.com

Corinna Schumacher, LL.M.

Senior Associate

+352 271802-81

corinna.schumacher@gsk-lux.com

© GSK Stockmann 2021